The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine.
Nicole C Wright, Anne C Looker, Kenneth G Saag...
https://pubmed.ncbi.nlm.nih.gov/24771492/Actively Recruiting
Led by Martin Blomberg Jensen · Updated on 2026-09-17
20000
Participants Needed
1
Research Sites
N/A
Total Duration
This research investigates the role of two hormones, luteinizing hormone LH and human chorionic gonadotropin hCG, in adults undergoing assessment for endocrine disorders. It explores how changes in these hormones, especially during menopause and aging, may affect various body systems beyond reproduction. The study aims to understand their association with the presence, severity, and long-term outcomes of endocrine diseases such as osteoporosis, thyroid disorders, adrenal gland disease, and others. Participants in this observational study will have their blood tested for LH, hCG, and other related hormones and biomarkers. The research includes adult patients referred for endocrine evaluation, covering a range of suspected endocrine conditions. The study will track these hormone levels and link them to health outcomes using national health registries over follow-up periods of up to 15 years. During the study, participants will undergo blood sample collection and hormone level measurement. Researchers will analyze associations between hormone levels and risks of fractures, osteoporosis, thyroid treatment initiation, adrenal tumors, and other endocrine complications. The study involves long-term monitoring through health registries to assess these outcomes and improve understanding of LH and hCG as potential biomarkers for endocrine diseases. Participation spans several years, with follow-up measurements at 5, 10, and 15-year intervals.
CONDITIONS
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
M
Martin B Jensen, Professor
M
Mads J Jorsal, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Martin Blomberg Jensen
Lead Sponsor
Copenhagen University Hospital at Herlev
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Nicole C Wright, Anne C Looker, Kenneth G Saag...
https://pubmed.ncbi.nlm.nih.gov/24771492/J R Center, T V Nguyen, D Schneider...
https://pubmed.ncbi.nlm.nih.gov/10093980/Martin Blomberg Jensen, Christine Hjorth Andreassen, Anne Jørgensen...
https://pubmed.ncbi.nlm.nih.gov/33893301/Sultana Monira Hussain, Ego Seeman, Hans G Schneider...
https://pubmed.ncbi.nlm.nih.gov/38426788/Li Juel Mortensen, Ireen Kooij, Mette Lorenzen...
https://pubmed.ncbi.nlm.nih.gov/38852333/Periklis Dousdampanis, Konstantina Trigka, Costas Fourtounas...
https://pubmed.ncbi.nlm.nih.gov/24119223/Lisa M Neff, Mindy E Hoffmann, Dinah M Zeiss...
https://pubmed.ncbi.nlm.nih.gov/28111609/Ding Na, Guo Tao, Liu Shu-Ying...
https://pubmed.ncbi.nlm.nih.gov/34416890/Rune Holt, Sam Kafai Yahyavi, Ireen Kooij...
https://pubmed.ncbi.nlm.nih.gov/37555466/Alessandro Prete, Irina Bancos
https://pubmed.ncbi.nlm.nih.gov/38649778/Martin Blomberg Jensen
Lead Sponsor
Copenhagen University Hospital at Herlev
Collaborating Sponsor